Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Wells Fargo & Company MN

Wells Fargo & Company MN raised its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 368,941 shares of the company's stock after acquiring an additional 11,811 shares during the period. Wells Fargo & Company MN owned approximately 0.20% of Doximity worth $19,698,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Morse Asset Management Inc acquired a new position in shares of Doximity during the 3rd quarter valued at $46,000. Orion Portfolio Solutions LLC purchased a new position in Doximity in the third quarter valued at about $260,000. Barclays PLC lifted its stake in shares of Doximity by 60.5% during the third quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after purchasing an additional 20,125 shares in the last quarter. M&T Bank Corp purchased a new stake in shares of Doximity in the third quarter worth about $351,000. Finally, Geode Capital Management LLC grew its stake in shares of Doximity by 19.8% in the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock valued at $124,503,000 after buying an additional 472,565 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Performance

Shares of Doximity stock traded up $0.35 during trading on Thursday, hitting $53.13. 1,400,802 shares of the stock were exchanged, compared to its average volume of 1,976,053. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The stock's fifty day moving average is $64.00 and its 200 day moving average is $55.61. The stock has a market cap of $9.92 billion, a PE ratio of 53.20, a P/E/G ratio of 4.10 and a beta of 1.41.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on DOCS. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and raised their price target for the company from $31.00 to $78.00 in a report on Friday, February 7th. Mizuho boosted their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. The Goldman Sachs Group raised their target price on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, KeyCorp cut their price target on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Doximity currently has an average rating of "Moderate Buy" and a consensus target price of $65.00.

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 37.40% of the stock is owned by company insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.